251 related articles for article (PubMed ID: 20451879)
1. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.
Ellis KA; Rowe CC; Villemagne VL; Martins RN; Masters CL; Salvado O; Szoeke C; Ames D;
Alzheimers Dement; 2010 May; 6(3):291-6. PubMed ID: 20451879
[TBL] [Abstract][Full Text] [Related]
2. Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging.
Lui JK; Laws SM; Li QX; Villemagne VL; Ames D; Brown B; Bush AI; De Ruyck K; Dromey J; Ellis KA; Faux NG; Foster J; Fowler C; Gupta V; Hudson P; Laughton K; Masters CL; Pertile K; Rembach A; Rimajova M; Rodrigues M; Rowe CC; Rumble R; Szoeke C; Taddei K; Taddei T; Trounson B; Ward V; Martins RN; AIBL Research Group
J Alzheimers Dis; 2010; 20(4):1233-42. PubMed ID: 20413897
[TBL] [Abstract][Full Text] [Related]
3. Japanese Alzheimer's Disease Neuroimaging Initiative: present status and future.
Iwatsubo T
Alzheimers Dement; 2010 May; 6(3):297-9. PubMed ID: 20451880
[TBL] [Abstract][Full Text] [Related]
4. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
Ellis KA; Bush AI; Darby D; De Fazio D; Foster J; Hudson P; Lautenschlager NT; Lenzo N; Martins RN; Maruff P; Masters C; Milner A; Pike K; Rowe C; Savage G; Szoeke C; Taddei K; Villemagne V; Woodward M; Ames D;
Int Psychogeriatr; 2009 Aug; 21(4):672-87. PubMed ID: 19470201
[TBL] [Abstract][Full Text] [Related]
5. [Current topics about mild cognitive impairment (MCI)].
Yamamoto Y
Seishin Shinkeigaku Zasshi; 2011; 113(6):584-92. PubMed ID: 21815470
[TBL] [Abstract][Full Text] [Related]
6. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.
Rowe CC; Ellis KA; Rimajova M; Bourgeat P; Pike KE; Jones G; Fripp J; Tochon-Danguy H; Morandeau L; O'Keefe G; Price R; Raniga P; Robins P; Acosta O; Lenzo N; Szoeke C; Salvado O; Head R; Martins R; Masters CL; Ames D; Villemagne VL
Neurobiol Aging; 2010 Aug; 31(8):1275-83. PubMed ID: 20472326
[TBL] [Abstract][Full Text] [Related]
7. Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: an update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study.
Ellis KA; Rainey-Smith SR; Rembach A; Macaulay SL; Villemagne VL;
Int Rev Psychiatry; 2013 Dec; 25(6):699-710. PubMed ID: 24423223
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
Mosconi L; De Santi S; Rusinek H; Convit A; de Leon MJ
Expert Rev Neurother; 2004 Sep; 4(5):831-49. PubMed ID: 15853510
[TBL] [Abstract][Full Text] [Related]
9. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
10. Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease.
Zamrini E; De Santi S; Tolar M
Neurobiol Aging; 2004; 25(5):685-91. PubMed ID: 15172748
[TBL] [Abstract][Full Text] [Related]
11. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL).
Ellis KA; Szoeke C; Bush AI; Darby D; Graham PL; Lautenschlager NT; Macaulay SL; Martins RN; Maruff P; Masters CL; McBride SJ; Pike KE; Rainey-Smith SR; Rembach A; Robertson J; Rowe CC; Savage G; Villemagne VL; Woodward M; Wilson W; Zhang P; Ames D;
Int Psychogeriatr; 2014 Apr; 26(4):543-54. PubMed ID: 24252258
[TBL] [Abstract][Full Text] [Related]
12. Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment.
Tolboom N; van der Flier WM; Yaqub M; Koene T; Boellaard R; Windhorst AD; Scheltens P; Lammertsma AA; van Berckel BN
Neurology; 2009 Dec; 73(24):2079-85. PubMed ID: 20018636
[TBL] [Abstract][Full Text] [Related]
13. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).
Lim YY; Jaeger J; Harrington K; Ashwood T; Ellis KA; Stöffler A; Szoeke C; Lachovitzki R; Martins RN; Villemagne VL; Bush A; Masters CL; Rowe CC; Ames D; Darby D; Maruff P
Arch Clin Neuropsychol; 2013 Jun; 28(4):320-30. PubMed ID: 23552802
[TBL] [Abstract][Full Text] [Related]
14. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease.
Luo F; Rustay NR; Ebert U; Hradil VP; Cole TB; Llano DA; Mudd SR; Zhang Y; Fox GB; Day M
Neurobiol Aging; 2012 May; 33(5):933-44. PubMed ID: 20961663
[TBL] [Abstract][Full Text] [Related]
15. Maximizing the Alzheimer's Disease Neuroimaging Initiative II.
Carrillo MC; Sanders CA; Katz RG
Alzheimers Dement; 2009 May; 5(3):271-5. PubMed ID: 19362888
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease neuroimaging initiative in Europe.
Frisoni GB
Alzheimers Dement; 2010 May; 6(3):280-5. PubMed ID: 20451877
[TBL] [Abstract][Full Text] [Related]
17. [Neuroimaging Alzheimer's disease: early diagnosis, monitoring, and mechanism understanding].
Chételat G
Med Sci (Paris); 2011 Feb; 27(2):193-8. PubMed ID: 21382329
[TBL] [Abstract][Full Text] [Related]
18. Automated (11)C-PiB standardized uptake value ratio.
Raniga P; Bourgeat P; Fripp J; Acosta O; Villemagne VL; Rowe C; Masters CL; Jones G; O'Keefe G; Salvado O; Ourselin S
Acad Radiol; 2008 Nov; 15(11):1376-89. PubMed ID: 18995189
[TBL] [Abstract][Full Text] [Related]
19. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.
Burnham SC; Raghavan N; Wilson W; Baker D; Ropacki MT; Novak G; Ames D; Ellis K; Martins RN; Maruff P; Masters CL; Romano G; Rowe CC; Savage G; Macaulay SL; Narayan VA; ;
J Alzheimers Dis; 2015; 46(4):1079-89. PubMed ID: 26402634
[TBL] [Abstract][Full Text] [Related]
20. Utility of imaging for nutritional intervention studies in Alzheimer's disease.
de Wilde MC; Kamphuis PJ; Sijben JW; Scheltens P
Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S59-69. PubMed ID: 21816137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
